Genetic signature may predict lung cancer response to immuno

A new study has identified a set of 140 genes that may help predict enhanced disease-free survival in patients with non-small-cell lung cancer treated with a combination of immunotherapy and low-dose radiation.

Related Keywords

Nasser Altorki , Olivier Elemento , Timothy Mcgraw , Weill Cornell , Davidb Skinner , Englander Institute For Precision Medicine , Cell Medicine Reports , Thoracic Surgery , Weill Cornell Medicine , Englander Institute ,